• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Repros Therapeutics Inc

+ Add to Watchlist

RPRX:US

15.2200 USD 0.7300 5.04%

As of 17:20:00 ET on 08/21/2014.

Snapshot for Repros Therapeutics Inc (RPRX)

Open: 14.4800 Day's Range: 14.4301 - 15.7700 Volume: 695,165
Previous Close: 14.4900 52wk Range: 12.6100 - 29.7900 1-Yr Rtn: -20.23%

Stock Chart for RPRX

No chart data available.
  • RPRX:US 15.2200
  • 1D
  • 1M
  • 1Y
14.4900
Interactive RPRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RPRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.3200
Est. EPS (USD) (12/2014) -1.5200
Est. PEG Ratio -
Market Cap (M USD) 351.73
Shares Outstanding (M) 23.11
30 Day Average Volume 217,643
Price/Book (mrq) 5.8431
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RPRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RPRX

Repros Therapeutics Inc. is a clinical stage biopharmaceutical company. The Company develops new drugs to treat hormonal and reproductive system disorders.

Joseph S PodolskiPresident/CEOKatherine A AndersonCFO/Secretary
Joachim F WernickeChief Medical OfficerJaye L ThompsonSenior VP:Clinical & Regulatory
More Company Profile & Key Executives for RPRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil